Skip to content

Author

R. Văruţ

We have 3 of 69 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Plant-Derived Control of Postprandial Glycemia: α-Amylase, α-Glucosidase, and the Incretin-DPP-4 Interface

Postprandial hyperglycemia can be modified before absorbed glucose reaches the circulation. Plant-derived compounds may slow starch hydrolysis through α-amylase and intestinal α-glucosidases, stimulate glucagon-like peptide-1 (GLP-1) release, or preserve incretin activity through dipeptidyl peptidase-4 (DPP-4) inhibiti...

Pirscoveanu Denisa Floriana Vasilica, D. Trașcă, A. Kamal et al. · 0 citations
Review Open access Aug 2026

From Plant Chemistry to Reproducible Antidiabetic Products: A Critical Review of Molecular Targets, Clinical Evidence, and Translational Gaps

Diabetes mellitus results from insulin resistance, progressive pancreatic β-cell dysfunction, dysregulated hepatic and adipose metabolism, oxidative stress, and inflammation. Plant-derived compounds can modulate several of these processes, yet pharmacological breadth does not necessarily produce a reproducible therapy....

Pirscoveanu Denisa Floriana Vasilica, D. Trașcă, A. Kamal et al. · 0 citations
Review Open access Aug 2026

From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments

Achondroplasia is increasingly understood as a disorder of dysregulated growth plate signaling rather than solely a condition of reduced stature and vosoritide provides clinical proof that pharmacological modulation of FGFR3-related signaling can improve growth velocity.

R. Șerban, Andreea-Mădălina Mituț-Velișcu, Alexandra-Aurora Dumitra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.